Company news
Crism Therapeutics Corporation (LSE:CRTX) news
Crism Therapeutics Corporation news releases on 6ix. Latest, Oct 2, 2026: Notice of AGM
Press releases & updates
Notice of AGM
October 2, 2026
Appointment of Non-executive Chair
September 17, 2026
Commencement of Patient Recruitment
August 20, 2026
Result of Shareholder Analysis
July 27, 2026
Grant of Options
June 30, 2026
FINAL RESULTS
June 26, 2026
Result of General Meeting
June 15, 2026
Significant Grant Award
June 4, 2026
Grant Award
June 1, 2026
Notice of General Meeting
May 27, 2026
Retail Offer to raise up to £100,000
May 26, 2026
Positive Preclinical Data for Docetaxel ChemoSeed
April 21, 2026
Board Changes
April 2, 2026
Phase 2 Clinical Trial Progress Update
March 25, 2026
Awarding of Orphan Drug Designation by the FDA
March 17, 2026
Japanese Patent Grant
January 20, 2026
Results of Shareholder Analysis
January 9, 2026
Result of Retail Offer
December 15, 2025
Retail Offer
December 10, 2025
Holding(s) in Company
November 27, 2025
US Orphan Drug Designation Application
October 30, 2025
Positive Preclinical Data in Prostate Cancer
October 14, 2025
Half Year Report
September 15, 2025
Notice of Interim Results and IMC Presentation
September 12, 2025
Approval for phase 2 clinical trial
September 1, 2025
Result of AGM
August 26, 2025
GMP Manufacture of ChemoSeed
August 12, 2025
Notice of AGM and EMI Option Plan
August 4, 2025
Result of Retail Offer and Additional Placing
July 3, 2025
Update presentation on the IMC platform
July 1, 2025
Placing
June 30, 2025
Final Results for the year ended 31 December 2024
June 13, 2025
Best Paper Award
June 9, 2025
Establishment of Scientific Advisory Board
June 3, 2025
Director Dealing
April 7, 2025
Clinical Trial Update
March 31, 2025
Innovate UK Grant Award
March 27, 2025
Appointment of Specialist Clinical CRO
December 20, 2024
European Patent Grant
December 18, 2024
Interim Results
September 19, 2024
Notice of Interim Results & IMC Presentation
September 9, 2024
Delivery Method Validated in Peer Reviewed Journal
September 3, 2024
Innovation Passport Award
September 2, 2024
CRISM Signs Service Agreement Contract
July 30, 2024
Response to Movement in Share Price
July 3, 2024